Cumberland Pharmaceuticals Inc
CPIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001087294
No open-market purchases or sales by Cumberland Pharmaceuticals Inc insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $16.0M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Cumberland Pharmaceuticals Inc changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 29 | 32 | +3 |
| Shares | 2.76M | 2.47M | −292.6K (−10.6%) |
| Value | $8.97M | $16.0M | +$7.03M (+78.3%) |
New holders (8)
Institutions that held Cumberland Pharmaceuticals Inc at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bailard, Inc. | 24,624 | $159.6K | 0.00% |
| Quadrature Capital Ltd | 24,014 | $155.6K | 0.00% |
| Simplex Trading, LLC | 4,544 | $29.4K | 0.00% |
| Institute for Wealth Management, LLC. | 352 | $2.29K | 0.00% |
| Advisor Group Holdings, Inc. | 200 | $1.30K | 0.00% |
| Tower Research Capital LLC (TRC) | 191 | $1.24K | 0.00% |
| Barclays PLC | 48 | $311 | 0.00% |
| FMR LLC | 21 | $136 | 0.00% |
Sold out (5)
Institutions that held Cumberland Pharmaceuticals Inc at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| J. Goldman & Co LP | 81,040 | $263.4K |
| Acadian Asset Management LLC | 44,288 | $143.0K |
| Marex Group plc | 36,423 | $118.4K |
| Caitong International Asset Management Co., Ltd | 2 | $6 |
| Royal Bank of Canada | 127 | $0 |